Chester County News and Community Website
WASHINGTON, D.C. — Federal health regulators are investigating the death of an 8-year-old boy who received Elevidys, a gene therapy developed by Sarepta Therapeutics for Duchenne muscular dystrophy, a rare …
FDA Probes Death of Child Linked to Gene Therapy for Duchenne Muscular Dystrophy Read More
WASHINGTON, D.C. — The U.S. Department of Agriculture’s Foreign Agricultural Service (FAS) has opened applications for its next agribusiness trade mission to Mexico City, set for November 3–6. The mission …
USDA Launches Trade Mission to Mexico to Boost Booming Ag Exports and Protect U.S. Livestock Read More
WASHINGTON, D.C. — The U.S. Department of Agriculture recently announced the termination of the Regional Food Business Centers (RFBC) program, a pandemic-era initiative launched under the Biden administration. Secretary of …
Biden-Era Food Program Terminated—USDA Pledges to Honor Existing Farmer Awards Read More
ST. LOUIS, MO — The U.S. Department of Agriculture (USDA) recently unveiled a sweeping plan to modernize food safety enforcement, highlighted by the opening of a state-of-the-art Midwestern Food Safety …
USDA Unveils Bold Food Safety Overhaul With New High-Tech Lab in Missouri Read More
WASHINGTON, D.C.—In a sweeping policy shift aligned with President Donald J. Trump’s Energy Dominance agenda, the U.S. Department of the Interior has announced it will eliminate preferential treatment for wind …
Interior Department Ends Favoritism for Wind and Solar, Citing Push for ‘Energy Dominance’ Read More
PHILADELPHIA, PA — GSK plc recently received approval from the U.S. Food and Drug Administration (FDA) for a prefilled syringe version of SHINGRIX, the company’s vaccine for shingles (herpes zoster). The …
FDA Approves Prefilled Syringe for GSK’s Shingles Vaccine, Streamlining Immunization Process Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration on Friday placed Sarepta Therapeutics’ gene therapy trials for limb girdle muscular dystrophy on clinical hold following the deaths of three patients …
FDA Shuts Down Sarepta Gene Therapy Trials After Three Deaths Linked to Liver Failure Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has issued warning letters to seven companies accused of unlawfully marketing products containing 7-hydroxymitragynine (7-OH), a potent opioid compound derived …
FDA Targets 7-OH Kratom Products in Crackdown on Unapproved Opioid-Like Supplements Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved the use of gardenia (genipin) blue as a color additive in a range of food products, marking the fourth …
FDA Approves Gardenia Blue as Natural Dye in Major Move to Eliminate Synthetic Food Colors Read More
WASHINGTON, D.C. — The U.S. Department of the Interior announced last week the launch of the Patriot Program, a major three-year initiative aimed at revitalizing America’s public lands in celebration …
Interior Department Launches $250 Million “Patriot Program” to Restore Public Lands Ahead of America’s 250th Anniversary Read More